Skip to content

Impact of probiotic supplementation in treatment of periodontal patients with type 2 diabetes mellitus

Impact of probiotic supplementation on periodontal indices, lipid profile, inflammatory markers and Glycemic Control in periodontal patients with type 2 diabetes mellitus

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016110430694N1
Enrollment
50
Registered
2017-01-28
Start date
2016-11-15
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Impact of probiotic supplementation on periodontal indices, lipid profile, inflammatory markers and Glycemic Control in periodontal patients with type 2 diabetes mellitus. Non-insulin-dependent diabetes mellitus, Chronic periodontitis

Interventions

Intervention 1: Intervention: The intervention group receive probiotic supplement (500 mg as capsulated) for 8 weeks. Intervention 2: control: the control group receive placebo capsules containing whe
Intervention: The intervention group receive probiotic supplement (500 mg as capsulated) for 8 weeks.
control: the control group receive placebo capsules containing wheat flour (500 mg) for 8 weeks.

Sponsors

Vice Chancellor for research of Ahvaz Jundishapur University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Males and females aged (30 – 60 y); type 2 diabetic patients (at least 5 years of diagnosis) with chronic periodontal disease; BMI = 18.5 < 30kg/m2 Exclusion criteria: Diabetic complications such as renal failure; using insulin therapy; pregnancy; breast feeding; traveling greater than 1 weeks; smoking; using any dietary supplements including probiotic and antioxidant supplements; using immunosuppressive medications; history of periodontal therapy; following specific diet; changing usual diet and planning to weight loss

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Fasting blood sugar. Timepoint: Immediately Before and after the intervention. Method of measurement: Using enzymatic kits.;IL-6. Timepoint: Immediately Before and after the intervention. Method of measurement: Elisa.;Hb-A1c. Timepoint: Immediately Before and after the intervention. Method of measurement: Elisa.;Hs-CRP. Timepoint: Immediately Before and after the intervention. Method of measurement: Elisa.;TNF-a. Timepoint: Immediately Before and after the intervention. Method of measurement: Elisa.;Total cholesterol. Timepoint: Immediately Before and after the intervention. Method of measurement: Using enzymatic kits.;HDL-C. Timepoint: Immediately Before and after the intervention. Method of measurement: Using enzymatic kits.;LDL-C. Timepoint: Immediately Before and after the intervention. Method of measurement: Using enzymatic kits.;TG. Timepoint: Immediately Before and after the intervention. Method of measurement: Using enzymatic kits.;Bleeding during probe. Timepoint: Immediately Before and after the intervention. Method of measurement: Evaluation of bleeding.;Plaque index. Timepoint: Immediately Before and after the intervention. Method of measurement: Plaque is on the tooth surface.;Pocket dept. Timepoint: Immediately Before and after the intervention. Method of measurement: The probing depth is measured by the probe.;Clinical attachment level. Timepoint: Immediately Before and after the intervention. Method of measurement: Depth study of cement and enamel plaque periodontal.

Countries

Iran (Islamic Republic of)

Contacts

Public Contactmohsen yarahmadi

Ahvaz Jundishapur University of Medical Sciences

yarahmadi14671@gmail.com+98 74 3333 1257

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026